Effects of Telemonitoring in Quality of Life Amongst Cancer Patients

Summary

This interventional study aims to explore the potential of a smartphone app, Contigo, in enhancing the quality of life for patients with various cancers compared to standard care. The investigators will asses effects on quality of life, depressive symptoms, and appointment adherence.

Eligibility

Inclusion Criteria:

* Adult patients (\>18 years old).
* Recent histologically confirmed diagnosis (within the last 3 months) of bronchogenic, breast, gallbladder, gastric, colorectal, or prostate cancer in any of its forms.
* Awaiting initiation of curative intent treatment for the disease using any modality (radiation therapy, chemotherapy, immunotherapy, etc.) at the UC-Christus Cancer Center.
* Possession of a smartphone, regardless of its native operating system (iOS® or Android®).
* Willingness to sign an informed consent form to participate in the study.

Exclusion Criteria:

* Any form of sensory impairment preventing app usage.
* Cognitive impairment.
* Psychiatric pathology hindering app usage.
* Unwillingness to participate in the study.
* Concurrent participation in another clinical trial addressing healthcare technologies.

Conditions5

Browse More Trials